Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSAMPRENAVIR vs FOSCARBIDOPA\FOSLEVODOPA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSAMPRENAVIR vs FOSCARBIDOPA\FOSLEVODOPA: Safety Overview

Metric FOSAMPRENAVIR FOSCARBIDOPA\FOSLEVODOPA
Total FAERS Reports 460 3,161
Deaths Reported 31 431
Death Rate 6.7% 13.6%
Hospitalizations 91 1,747
Average Patient Age 45.3 yrs 70.4 yrs
% Female Patients 27.9% 42.2%
FDA Approval Date Apr 15, 2016 N/A
Manufacturer Sun Pharmaceutical Industries, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A